The Medical Hot Melt Adhesive Patch segmentation by application isolates three primary use‑cases: Wound Care, Drug Delivery, and Diagnostic Monitoring. Wound Care patches dominate the market, accounting for roughly 45% of revenue, because they replace sutures in minor procedures, reduce infection risk, and enable rapid hemostasis, driving volume in surgical centers and outpatient clinics. Drug Delivery patches represent about 40% of the market; they embed active pharmaceutical ingredients within the hot‑melt matrix, offering controlled release for chronic pain, hormone therapy, and vaccination, which expands the addressable patient pool and sustains higher price points. Diagnostic Monitoring patches, though smaller at 15%, support biosensor integration for continuous glucose or cardiac monitoring, a niche that benefits from premium pricing and growing tele‑health adoption. Collectively, these application segments define the market’s size by aligning product design, regulatory pathways, and reimbursement structures with distinct clinical value propositions.